Overview Rating

Good

Unlock major analysts' bullish and bearish positions by joining Benzinga Edge.

Click Here

Technicals Analysis

0100

Financials Analysis

0100

United Therapeutics (NASDAQ:UTHR) Stock Quotes, Forecast and News Summary

Q: What sector and industry does United Therapeutics (UTHR) operate in?

United Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

United Therapeutics Stock (NASDAQ: UTHR) stock price, news, charts, stock research, profile.

Open	$331.94
Close	-
Volume / Avg.	23.28K / 568.24K
Day Range	331.53 - 335.38
52 Wk Range	208.62 - 339.56
Market Cap	$14.87B
P/E Ratio	15.75
Dividend Yield	-
Exchange	NASDAQ
RSI	73
Short Interest	13.12%
Days to Cover	5.38

Recent News

Perrigo Q1 Earnings Surpass, Sales Miss Estimates

Perrigo Company plc (NYSE: PRGO) reported adjusted earnings of 29 cents per share in the first quarter of 2024, beating the Zacks Consensus Estimate of 24 cents. Earnings were down 35.6% year over year, primarily due to a negative financial impact of 30 cents per share from infant formula.

Zacks

Lung Disease-Focused United Therapeutics Says It Is A Compelling Investment Opportunity

United Therapeutics impresses with record-breaking Q1 results. Revenue soars 34% Y/Y to $677.7 million, EPS jumps to $6.17. Tyvaso leads the charge with a 56% revenue surge.

Vandana Singh

Powell Industries Posts Upbeat Results, Joins A10 Networks, Garmin, DuPont And Other Big Stocks Moving Higher On Wednesday

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Feb

Mar

May

Jun

Jul

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

About United Therapeutics Corp

Sector

Health Care

Industry

Biotechnology

United Therapeutics specializes in drug development for pulmonary arterial hypertension, a rare and ...

Compare

EPS better than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS better than industry

FAQ

How do I buy United Therapeutics (UTHR) stock?

You can purchase shares of United Therapeutics (NASDAQ:UTHR) through any online brokerage.

View our list of the best stock brokerages

Who are United Therapeutics (UTHR) competitors?

Other companies in United Therapeutics’s space includes: Legend Biotech (NASDAQ:LEGN), Sarepta Therapeutics (NASDAQ:SRPT), Exact Sciences (NASDAQ:EXAS), Neurocrine Biosciences (NASDAQ:NBIX) and Cerevel Therapeutics Hldg (NASDAQ:CERE).

What is the target price for United Therapeutics (UTHR) stock?

There is no analysis for United Therapeutics.

What is the forecast for United Therapeutics (UTHR) stock?

United Therapeutics has a consensus price target of $306.87.

Current stock price for United Therapeutics (UTHR)?

The stock price for United Therapeutics (NASDAQ: UTHR) is $335.15 last updated Today at July 23, 2024 at 10:22 AM EDT.

Does United Therapeutics (UTHR) pay a dividend?

There are no upcoming dividends for United Therapeutics.

When is United Therapeutics (NASDAQ:UTHR) reporting earnings?

United Therapeutics’s Q2 earnings are confirmed for Monday, August 5, 2024.

Is United Therapeutics (UTHR) going to split?

There is no upcoming split for United Therapeutics.

What sector and industry does United Therapeutics (UTHR) operate in?

United Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Comments

United Therapeutics

United Therapeutics (UTHR) Forecast